Miyaji Katsumasa | Division of Cardiology, National Hospital Organization Okayama Medical Center

スポンサーリンク

概要

関連著者

もっと見る

著作論文

OJ-043 Inhibitory Effects of Simvastatin and Imatinib on PDGF-induced Proliferation and Migration of Smooth Muscle Cells Obtained from Patients with IPAH(OJ08,Pulmonary Circulation (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The
PJ-606 Pulmonary Veno-occlusive Disease : Acute Vasodilator Response and Prognosis(PJ102,Pulmonary Circulation 2 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
Marked Hemodynamic Improvements by High-Dose Epoprostenol Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension
PJ-607 Vascular Endothelial Growth Factor and Platelet Derived Growth Factor in Patients with Pulmonary Arterial Hypertension(PJ102,Pulmonary Circulation 2 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Societ
PJ-516 Predictive Factors of Restenosis after Paclitaxel-Eluting Stent Implantation(PJ087,Coronary Revascularization, PCI (Restenosis/Others) 2 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
PE-512 Prognostic Predictive Factor in Pulmonary Arterial Hypertension Patients Treated with Epoprostenol(PE086,Pulmonary Circulation (H),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
OJ-044 Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension : Better Alternative to Medical Therapy(OJ08,Pulmonary Circulation (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circ
OE-109 Targeted Therapy Drug Imatinib Provided Beneficial Short-term Effect in Patients with Refractory Pulmonary Arterial Hypertension(OE19,Pulmonary Circulation (H),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulati
Morphologically Unique Feature of Recurrent Ampulla (Takotsubo) Cardiomyopathy
Additional Effects of Bosentan in Patients With Idiopathic Pulmonary Arterial Hypertension Already Treated With High-Dose Epoprostenol
OE-225 Structural Characteristics of Pulmonary Microvasculature in Patients with Pulmonary Hypertension(Pulmonary circulation(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
OE-224 Pulmonary Arterial Augmentation Index Reflects Disease Severity in Patients with Pulmonary Arterial Hypertension(Pulmonary circulation(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
Prevention of Catheter-Related Infections Using A Closed Hub System in Patients With Pulmonary Arterial Hypertension
PJ-832 Epoprostenol Improves the Vasoreactivity to Oxygen in Patients with PAH(Pulmonary circulation-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PJ-445 Negative Inotropic Effect Induced by Cyclic GMP Would be an Underlying Mechanism of Takotsubo Cardiomyopathy(Cardiomyopathy, basic/clinical-7, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
1 Short and Long Term Effect of the Combination Therapy of Epoprostenol and Bosentan for Patients with Pulmonary Arterial Hypertension(Diagnosis and Treatment of Pulmonary Hypertension, The 71st Annual Scientific Meeting of the Japanese Circulation Societ
PE-294 Application of Prostacyclin to Patients with Pulmonary Venoocclusive Disease and Pulmonary Capillary Hemangiomatosis(Pulmonary circulation-3 (H) PE49,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulatio
The ratio of the atrial areas reflects the clinical status of patients with pulmonary arterial hypertension
PJ-824 The Usefulness of the Ratio of Both Atrial Areas for Assessment of Therapeutic Effects on Patients with Pulmonary Arterial Hypertension(Pulmonary circulation-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Safety and Efficacy of Epoprostenol Therapy in Pulmonary Veno-Occlusive Disease and Pulmonary Capillary Hemangiomatosis

もっと見る

スポンサーリンク